- Home
- INTA vs SRRK Comparison
INTA vs SRRK Comparison
Compare INTA & SRRK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | INTA | SRRK |
|---|---|---|
| Founded | 2000 | 2012 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Prepackaged Software | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.9B | 4.6B |
| IPO Year | 2021 | 2018 |
Fundamental Metrics
Financial Performance| Metric | INTA | SRRK |
|---|---|---|
| Price | $46.08 | $44.13 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 9 | 9 |
| Target Price | ★ $59.63 | $47.88 |
| AVG Volume (30 Days) | 502.0K | ★ 1.2M |
| Earning Date | 02-03-2026 | 11-14-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $524,342,000.00 | N/A |
| Revenue This Year | $15.67 | N/A |
| Revenue Next Year | $13.37 | $20,271.77 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 17.11 | N/A |
| 52 Week Low | $35.51 | $22.71 |
| 52 Week High | $77.74 | $48.28 |
Technical Indicators
Market Signals| Indicator | INTA | SRRK |
|---|---|---|
| Relative Strength Index (RSI) | 56.35 | 55.32 |
| Support Level | $45.66 | $42.61 |
| Resistance Level | $47.88 | $46.14 |
| Average True Range (ATR) | 1.13 | 1.82 |
| MACD | 0.01 | -0.49 |
| Stochastic Oscillator | 63.23 | 30.63 |
Price Performance
Historical ComparisonAbout INTA Intapp Inc.
Intapp Inc is a provider of industry-specific, cloud-based software solutions for the professional and financial services industry. It empowers private capital,g, legal, accounting, and consulting firms with the technology needed to meet rapidly changing client, investor, and regulatory requirements. Geographically, it derives a majority of its revenue from the United States and also has a presence in the United Kingdom and the Rest of the world.
About SRRK Scholar Rock Holding Corporation
Scholar Rock Holding Corp is a late-stage biopharmaceutical company focused on discovering, developing, and delivering innovative medicines for treating serious diseases in which signaling by protein growth factors plays a fundamental role. Its pipeline includes Neuromuscular and Obesity, Immuno-oncology, Fibrotic Disease, and Hematology. The group operates and manages its business as a single segment to assess performance and make operating decisions.